Donna J. Edmonds

Ischemia Technologies, Inc. develops, manufactures and markets vitro diagnostic products with a focus on cardiovascular and acute care medicine. The Company was acquired by Inverness Medical Innovations, Inc. in March 2005. The company is headquartered in Denver, CO.

Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York.

Vital Sensors Holding Co., Inc. Develops chip based pressure sensors. It offers continuous or on demand data capture and read out capabilities that will support clinicians and patients in the management of cardiovascular and other disease state. The company was founded in 2002 by Volker Bödecker and Max Georg Ostermeier and is headquartered in Richmond, VA.

ImmunArray Ltd. develops novel in-vitro diagnostic tests. Its products support a personalized medicine approach and IAL's first product family will provide tests for diagnosis, prognosis and therapeutic guidance of autoimmune diseases and for improving transplantation medicine. The firm is in the process of developing its first product family of blood tests for screening, detection and monitoring of autoimmune diseases and transplant rejection. The company was founded by Eli Sahar & Irun Cohen in 2006 and is headquartered in Rehovot, Israel.

Cardiovascular Group provides cardiovascular services.

Virginia Life Science Investments LLC invests in off-shore life science companies. Its portfolio is primarily focused on companies that specialize in medical devices and diagnostics and range from simple devices through platform technologies. The company was founded on April 2, 2009 and is headquartered in Richmond, VA.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

NeatStitch Ltd. develops and manufactures medical devices. It offers NeatClose, a patented Nitinol based automatic suturing product primarily targeting the Laparoscopic Port Closure Market. The firm’s product is FDA approved and employs a simple-intuitive blunt end design therefore avoiding exposed needles and improving the safety and speed of the closure for each procedure. The company was founded in 2004 by Assaf Dekel and is headquartered in Or Akiva, Israel.

Xenolith Medical Ltd. develops and manufactures medical devices. Its product XenX involves a very thin mesh structure that is constructed as an integral part of a guide wire. The firm is also developing additional tools in the endourological niche. The company was founded by Shaul Shohat and Ido Kilemnik in 2010 and is headquartered in Or Akiva, Israel.